Fundamental research studies

Status: Study in progress - Recruitment completed
Number of volunteers: 100
​​​​​​​Length of the study: 2 visits (1h and 3h)

Standardization and Validation of immunologic assays, and evaluation of the specific T cells immune response to different viruses.

The goal of this study is to carry out a systematic study of the immune response against viruses that are very widespread and generally well-controlled like the CMV (Cytomegalovirus), and the EBV (Epstein Barr Virus), in order to better understand which parameters are involved in the effective control of these viruses and to identify the defective parameters of the immune response against HIV. These immune response analyses are handled on a cell population called T lymphocytes from the blood. The lymphocytapheresis technique enables to collect a large number of cells (4 to 10 billion of cells) with a small amount of blood (100mL). These cells will be used in order to perform analyses to better understand the immune response of known and well controlled viruses.

For this study, we are recruiting healthy volunteers, aged between 18 and 60 years.

For further information on this study, please contact us by phone +41 21 314 1160 / +41 21 314 1163.

Status: Study completed
Number of volunteers: 5
​​​​​​​Length of the study: 2 visits (1h and 3h)

Characterization of the T immune response (T lymphocytes) in HIV seropositive patients with classic evolution and in Long Term Non Progressors (LTNP) patients.

This study is part of HIV research and aims to better understand mechanisms which enable Long Term Non Progressors (LTNP) patients to control the infection. In order to know more about these control mechanisms, some comparison of the immune response between classic evolution patients and LTNP patients should be done. These immune response analyses are handled on a cell population called T lymphocytes from the blood. The lymphocytapheresis technique enables to collect a large number of cells (4 to 10 billion of cells) with a small amount of blood (100mL). These cells will be used in order to perform analyses to better understand these patients immune response. Moreover, these study results may contribute to the development of new HIV vaccine strategies.

For this study, we are recruiting HIV infected patients, aged between 18 and 60 years. For further information on this study, please contact us by phone +41 21 314 1160 / +41 21 314 1163.

Contact us

Division of Immunology and Allergy
Vaccine and Immunotherapy Center (VIC)
Rue du Bugnon 17, BU17-01-119
Casier 41
1011 Lausanne

Monday to Friday: 8 am - 5 pm
Tél. +41 21 314 1160
Tél. +41 21 314 1155
 Dernière mise à jour le 18/08/2021 à 15:29